Known information
- Holds an MBA
- Previously worked at Replimune
- Has experience in business development and strategic partnerships
- Has a background in the biopharmaceutical industry
About Accent Therapeutics
Accent Therapeutics, based in Lexington, MA, develops small molecule therapeutics targeting RNA-modifying proteins for cancer treatment. The company has a partnership with AstraZeneca and has raised $75 million in Series C financing.